State Ledger
Company profile

LISATA THERAPEUTICS, INC. CIK 320017

Ticker
LSTA (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Basking Ridge, NJ 07920
Fiscal year end
2025 (FY)
Market Data
Close
$1.01
Change
-$0.02
Change %
-1.94%
Volume
7,545

LSTA · trading date Oct 12, 2026 · previous close $1.03 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$170.0K
Net income
-$16.59M
Total assets
$17.74M
Total liabilities
$3.14M
Stockholders' equity
$14.86M
Cash & equivalents
$15.96M
Operating income
-$18.21M
Operating cash flow
-$15.95M
Capital expenditures
$28.0K

Fiscal year 2025, via 10-K filed 2026-03-12. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-10,711.2%
Net margin
-9,756.5%
Free cash flow
-$15.98M
Free cash flow margin
-9,398.2%
Liabilities / assets
17.7%
Equity / assets
83.7%
CapEx / revenue
16.5%
Operating cash flow / net income
0.96×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $170.0K -$16.59M $17.74M $3.14M $14.86M
2024 $1.00M -$19.99M $35.00M $5.69M $29.57M
2023 $0 -$20.84M $54.69M $6.80M $48.15M
2022 $0 -$54.23M $73.03M $6.71M $66.58M
2021 — -$27.47M $97.01M $5.01M $92.25M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-17
Financials filed via
Form 10-K
filed 2026-03-12

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Basking Ridge, NJ 07920
110 ALLEN ROAD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:39 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies